These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 39082132)

  • 1. Steroidomics-Based Screening for Primary Aldosteronism: Impact of antihypertensive Drugs.
    Constantinescu G; Gruber S; Fuld S; Peitzsch M; Schulze M; Remde H; Kürzinger L; Yang J; Yen T; Williams TA; Müller L; Reincke M; Lenders JWM; Beuschlein F; Pamporaki C; Eisenhofer GF
    Hypertension; 2024 Oct; 81(10):2060-2071. PubMed ID: 39082132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between screening for primary aldosteronism with and without drug adjustment.
    Hua Y; He Q
    Blood Press; 2024 May; 33(1):2350981. PubMed ID: 38824645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
    Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Ramipril on the Aldosterone/Renin Ratio and the Aldosterone/Angiotensin II Ratio in Patients With Primary Aldosteronism.
    Guo Z; Poglitsch M; Cowley D; Domenig O; McWhinney BC; Ungerer JPJ; Wolley M; Stowasser M
    Hypertension; 2020 Aug; 76(2):488-496. PubMed ID: 32507039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralocorticoid Receptor Antagonists Decrease the Rates of Positive Screening for Primary Aldosteronism.
    Tezuka Y; Turcu AF
    Endocr Pract; 2020 Dec; 26(12):1416-1424. PubMed ID: 33471733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study.
    Rossi GP; Ceolotto G; Rossitto G; Maiolino G; Cesari M; Seccia TM
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32067030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
    Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
    Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of mineralocorticoid and AT-1 receptor antagonism on the aldosterone-renin ratio (ARR) in primary aldosteronism patients (EMIRA Study): rationale and design.
    Rossitto G; Cesari M; Ceolotto G; Maiolino G; Seccia TM; Rossi GP
    J Hum Hypertens; 2019 Feb; 33(2):167-171. PubMed ID: 30518805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.
    Mulatero P; Rabbia F; Milan A; Paglieri C; Morello F; Chiandussi L; Veglio F
    Hypertension; 2002 Dec; 40(6):897-902. PubMed ID: 12468576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical recommendations for antihypertensive therapy during the primary aldosteronism screening test.
    Li J; Yan H; Li L; Lin X; Zhao Z; Zhou C; Zhang Q
    Endocrine; 2024 Jan; 83(1):188-195. PubMed ID: 37924464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
    Pecori A; Buffolo F; Burrello J; Mengozzi G; Rumbolo F; Avataneo V; D'Avolio A; Rabbia F; Bertello C; Veglio F; Mulatero P; Monticone S
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3655-e3664. PubMed ID: 33942084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio.
    Gallay BJ; Ahmad S; Xu L; Toivola B; Davidson RC
    Am J Kidney Dis; 2001 Apr; 37(4):699-705. PubMed ID: 11273868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism.
    Jansen PM; van den Born BJ; Frenkel WJ; de Bruijne EL; Deinum J; Kerstens MN; Smulders YM; Woittiez AJ; Wijbenga JA; Zietse R; Danser AH; van den Meiracker AH
    J Hypertens; 2014 Jan; 32(1):115-26. PubMed ID: 24018605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension.
    Browne GA; Griffin TP; O'Shea PM; Dennedy MC
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):325-31. PubMed ID: 26300226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unadjusted Plasma Renin Activity as a "First-Look" Test to Decide Upon Further Investigations for Primary Aldosteronism.
    Rye P; Chin A; Pasieka J; So B; Harvey A; Kline G
    J Clin Hypertens (Greenwich); 2015 Jul; 17(7):541-6. PubMed ID: 25756935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of primary aldosteronism diagnosis in initial evaluation without medication withdrawal or confirmatory tests.
    Ruiz-Sánchez JG; Fernández Sánchez Á; Meneses D
    Endocrine; 2024 Aug; 85(2):906-915. PubMed ID: 38568364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of dietary salt intake on aldosterone and the aldosterone-to-renin ratio as screening parameters for primary aldosteronism.
    Koch M; Aker S; Haastert B; Rump LC
    Clin Nephrol; 2010 Sep; 74(3):182-9. PubMed ID: 20860902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How should anti-hypertensive medications be adjusted before screening for primary aldosteronism?
    Lu JY; Chang YY; Lee TW; Wu MH; Chen ZW; Huang YT; Lai TS; Er LK; Lin YH; Wu VC; Cheng HM; Kao HL; Jia-Yin Hou C; Wu KD; Chen ST; Liu FH
    J Formos Med Assoc; 2024 Mar; 123 Suppl 2():S91-S97. PubMed ID: 37291044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
    Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
    Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients].
    Chen SX; Du YL; Zhang J; Gong YC; Hu YR; Chu SL; He QB; Song YY; Zhu DL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):868-72. PubMed ID: 17217708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.